相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells
Dong Ren et al.
CELL AND TISSUE RESEARCH (2014)
T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness
Filipe Pinto et al.
CLINICAL CANCER RESEARCH (2014)
Phase I/II Trial of Orteronel (TAK-700)-an Investigational 17,20-Lyase Inhibitor-in Patients with Metastatic Castration-Resistant Prostate Cancer
Robert Dreicer et al.
CLINICAL CANCER RESEARCH (2014)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Axl Mediates Tumor Invasion and Chemosensitivity Through PI3K/Akt Signaling Pathway and Is Transcriptionally Regulated by Slug in Breast Carcinoma
Yanyan Li et al.
IUBMB LIFE (2014)
Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study
Matthew R. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway
Chun-Han Hou et al.
MOLECULAR CANCER (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Brachyury—a biomarker for progression and prognosis?
Clemens Thoma
Nature Reviews Urology (2014)
The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells
A. B. D'Assoro et al.
ONCOGENE (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
Epithelial plasticity in prostate cancer: principles and clinical perspectives
Rajdeep Das et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
Kouji Izumi et al.
EMBO MOLECULAR MEDICINE (2013)
IGF2 increases de novo steroidogenesis in prostate cancer cells
Amy A. Lubik et al.
ENDOCRINE-RELATED CANCER (2013)
Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis
Tzu-Hua Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer
Dana E. Rathkopf et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
Eva Karamitopoulou et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The receptor tyrosine kinase Ax1 is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
J. D. Paccez et al.
ONCOGENE (2013)
Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
T-H Lin et al.
CELL DEATH & DISEASE (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
Duane H. Hamilton et al.
ONCOTARGET (2013)
Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
Che-Kai Tsao et al.
BJU INTERNATIONAL (2012)
The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells
Miyuki Shimoda et al.
BMC CANCER (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
Mario Roselli et al.
CLINICAL CANCER RESEARCH (2012)
T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma
Ikumi Imajyo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease
Su Hyun Kim et al.
LABORATORY INVESTIGATION (2012)
Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer
Ruth Perets et al.
PLOS ONE (2012)
Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy
Aneel Bhangu et al.
SURGICAL ONCOLOGY-OXFORD (2012)
IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
Romaine I. Fernando et al.
CANCER RESEARCH (2011)
The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells
Seung-Keun Hong et al.
EXPERIMENTAL CELL RESEARCH (2011)
ERG gene rearrangements are common in prostatic small cell carcinomas
Tamara L. Lotan et al.
MODERN PATHOLOGY (2011)
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
Sean R. Williamson et al.
MODERN PATHOLOGY (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
Romaine I. Fernando et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Snail Transcription Factor Regulates Neuroendocrine Differentiation in LNCaP Prostate Cancer Cells
Danielle McKeithen et al.
PROSTATE (2010)
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression
Wei Ding et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Kati K. Waltering et al.
CANCER RESEARCH (2009)
Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
Ricardo M. Attar et al.
CLINICAL CANCER RESEARCH (2009)
Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression
Jiann-Jyh Lai et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
Philippe O. Gannon et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Shared TP53 Gene Mutation in Morphologically and Phenotypically Distinct Concurrent Primary Small Cell Neuroendocrine Carcinoma and Adenocarcinoma of the Prostate
Donna E. Hansel et al.
PROSTATE (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Antiangiogenic drugs and tyrosine kinases
Jozsef Timar et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Receptor tyrosine kinase inhibitors in thyroid cancer
Maria Domenica Castellone et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
AXL is a potential target for therapeutic intervention in breast cancer progression
Yi-Xiang Zhang et al.
CANCER RESEARCH (2008)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
Xiang-Bo Wan et al.
CARCINOGENESIS (2008)
EMT and MET in carcinoma - clinical observations, regulatory pathways and new models
Erik W. Thompson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression?
Eva A. Turley et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Epithelial-mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
Honor Hugo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration
Robert D. Loberg et al.
NEOPLASIA (2007)
Unusual and underappreciated: Small cell carcinoma of the prostate
Jeffrey S. Palmgren et al.
SEMINARS IN ONCOLOGY (2007)
Mesenchymal to epithelial transition in development and disease
Christine L. Chaffer et al.
CELLS TISSUES ORGANS (2007)
Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; A possible mechanism of hormone-resistance of prostate cancer cells
Naohiro Fujimoto et al.
CANCER INVESTIGATION (2007)
Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors
Latif A. Wafa et al.
HUMAN PATHOLOGY (2007)
Immunohistochemical characterization of neuroendocrine cells in prostate cancer
Jiaoti Huang et al.
PROSTATE (2006)
Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells
TC Yuan et al.
ENDOCRINE-RELATED CANCER (2006)
Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway
P Zhu et al.
CELL (2006)
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
N Vashchenko et al.
EUROPEAN UROLOGY (2005)
Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy
D Hirano et al.
EUROPEAN UROLOGY (2004)
Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: Association with tumor cell proliferation prior to recurrence
WJ Huss et al.
PROSTATE (2004)
Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells
XQ Zhang et al.
ONCOGENE (2003)
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells
ME Wright et al.
MOLECULAR ENDOCRINOLOGY (2003)
Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype
S Zelivianski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
分享论文
